Antidiabetic and hyperglycemic thiazolidinediones

1-Thio-beta-D-glucose tetraacetate

Biochem/physiol Actions MCC-555 is a thiazolidinedione class anti-diabetic compound. In rodent models, MCC-555 attenuates the development of diabetes, maintains B-cell function and improves insulin sensitivity.

Biochem/physiol Actions MCC-555 is a thiazolidinedione class anti-diabetic compound. In rodent models, MCC-555 attenuates the development of diabetes, maintains B-cell function and improves insulin sensitivity.

A cell-permeable triazolo compound that acts as a Sec7 domain-binding (K d &#8804250 nM for Sec7 from human cytohesins 1-3), selective antagonist against cytohesin family small GEFs (IC 50 &#88045.6 &#181M in ARF1 GDP/GTP exchange assays using

THX-B is a potent and non-peptidic p75 NTR (neurotrophin receptor p75) antagonist. THX-B can be used in the research of diabetic kidney disease, neurodegenerative and inflammatory disorders .In VitroTHX-B (10 μM, 4 days) decreases proliferation of

THX-B is a potent and non-peptidic p75 NTR (neurotrophin receptor p75) antagonist. THX-B can be used in the research of diabetic kidney disease, neurodegenerative and inflammatory disorders .In VitroTHX-B (10 μM, 4 days) decreases proliferation of